V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002075 | 230011883 | null | null | null | 2020-09-30 | 2020-10-01 | GemCarbo Days 1+8 | 02 | null | NIVOLUMAB | 101208932 |
| 230001344 | 230011895 | null | null | null | null | 2022-01-30 | null | null | null | CARBOPLATIN + PACLITAXEL | 100946609 |
| 230001361 | 230011896 | null | null | null | null | 2019-04-16 | null | null | null | CARBOPLATIN + PACLITAXEL | 100539577 |
| 230001662 | 230011899 | 1.6 | 56.6 | null | null | 2019-05-14 | null | null | null | BEVACIZUMAB | 100739333 |
| 230001787 | 230011900 | null | null | null | 2021-10-03 | 2021-10-11 | null | null | null | CAPECITABINE + OXALIPLATIN | 101286448 |
| 230001809 | 230011901 | 1.64 | 76 | null | 2020-07-23 | 2021-03-09 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100132664 |
| 230001955 | 230011902 | 1.62 | 70.3 | null | 2021-07-24 | 2021-07-30 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100203421 |
| 230002341 | 230011906 | null | null | null | null | 2021-08-02 | null | 01 | null | TRAMETINIB | 101105721 |
| 230002349 | 230011907 | 1.59 | 123.7 | null | 2022-05-19 | 2022-05-26 | null | null | null | CISPLATIN + ETOPOSIDE | 100379957 |
| 230002412 | 230011909 | 1.61 | 71 | null | 2022-03-20 | 2022-04-05 | Olaparib | 02 | null | OLAPARIB | 101528187 |
| 230001673 | 230011911 | 1.7 | 62 | null | 2019-11-03 | 2019-11-16 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101631811 |
| 230001787 | 230011920 | 1.52 | 71.3 | null | 2021-10-26 | 2021-11-02 | Niraparib | 02 | null | NIRAPARIB | 101286448 |
| 230002078 | 230011921 | null | null | Palliative (P) | 2021-12-03 | 2021-12-12 | Olaparib | 02 | null | OLAPARIB | 101221344 |
| 230002341 | 230011924 | 1.57 | 45.8 | null | 2017-07-28 | 2021-08-29 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101105721 |
| 230002412 | 230011927 | null | null | Palliative (P) | null | 2022-04-29 | null | 02 | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101528187 |
| 230001145 | 230011932 | null | 63.6 | null | null | 2022-04-15 | null | null | null | OLAPARIB | 101777462 |
| 230001361 | 230011933 | 1.65 | 61 | Palliative (P) | null | 2019-05-16 | Cytarabine Low Dose | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100539577 |
| 230002078 | 230011937 | null | null | null | null | 2021-12-12 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101221344 |
| 230002219 | 230011939 | 1.68 | 66.45 | Palliative (P) | 2020-01-04 | 2022-04-03 | null | null | N | PACLITAXEL | 100788570 |
| 230002341 | 230011940 | 1.6 | 51.5 | Adjuvant (A) | 2021-08-24 | 2021-09-07 | PACLITAXEL | 02 | N | PACLITAXEL | 101105721 |
| 230000998 | 230011945 | 1.51 | 59.2 | Palliative (P) | null | 2019-03-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100743210 |
| 230001026 | 230011946 | null | null | null | null | 2018-12-29 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100361159 |
| 230001361 | 230011947 | 1.72 | 59.4 | null | 2019-06-11 | 2019-06-12 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100539577 |
| 230002078 | 230011950 | 1.57 | 66 | null | 2021-12-30 | 2022-01-22 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101221344 |
| 230002219 | 230011951 | null | null | Adjuvant (A) | 2022-04-05 | 2022-04-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100788570 |
| 230001361 | 230011958 | 1.55 | 75.4 | Palliative (P) | null | 2019-06-25 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100539577 |
| 230002078 | 230011961 | 1.58 | 62.5 | null | 2022-03-04 | 2022-03-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101221344 |
| 230002219 | 230011962 | null | null | 03 | null | 2022-04-29 | TOPOTECAN | 02 | N | IPILIMUMAB | 100788570 |
| 230002341 | 230011963 | 1.53 | 72.6 | Palliative (P) | 2021-08-20 | 2021-08-26 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101105721 |
| 230002412 | 230011965 | 1.66 | 67.8 | null | 2022-04-29 | 2022-05-06 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101528187 |
| 230002412 | 230011974 | 1.59 | 76.9 | Palliative (P) | 2022-01-03 | 2022-05-26 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101528187 |
| 230001361 | 230011977 | null | 59 | null | null | 2019-06-03 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100539577 |
| 230002219 | 230011979 | 1.59 | 70.5 | Adjuvant (A) | 2022-01-20 | 2022-03-16 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100788570 |
| 230002219 | 230011986 | 1.61 | 81.4 | null | 2022-03-19 | 2022-04-11 | null | null | null | CISPLATIN | 100788570 |
| 230002219 | 230011991 | 1.55 | 44.8 | null | 2022-03-31 | 2022-04-08 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100788570 |
| 240000003 | 240000003 | 0 | 63.3 | Curative (C) | null | 2017-01-12 | null | 02 | N | BORTEZOMIB + THALIDOMIDE | 101364963 |
| 240000008 | 240000008 | 1.6 | 90 | 03 | null | 2019-06-19 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100930760 |
| 240000016 | 240000016 | null | null | null | null | 2018-09-26 | null | null | null | CYTARABINE | 100527702 |
| 240000020 | 240000020 | 1.61 | 60.5 | Curative (C) | 2014-04-19 | 2016-01-19 | null | null | null | AML19 TRIAL | 101578983 |
| 240000034 | 240000034 | null | null | null | null | 2017-11-27 | null | null | null | AZACITIDINE | 101370251 |
| 240000036 | 240000036 | null | null | null | null | 2019-05-20 | Rituximab | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 101209725 |
| 240000042 | 240000042 | 0 | 10.4 | Curative (C) | null | 2019-12-29 | CHOP R - 21 days | 02 | N | AZACITIDINE | 101372898 |
| 240000044 | 240000044 | 1.6 | 57.6 | Curative (C) | null | 2016-03-10 | CHOP - 21 days | 02 | N | HYDROXYCARBAMIDE | 101379143 |
| 240000056 | 240000056 | 1.62 | 76.5 | Curative (C) | null | 2017-02-02 | null | N | N | HYDROXYCARBAMIDE | 101773787 |
| 240000057 | 240000057 | null | null | null | null | 2018-09-19 | Azacitidine | null | null | IBRUTINIB | 101657599 |
| 240000059 | 240000059 | 0 | 0 | 03 | 2018-04-24 | 2018-04-24 | AML16 DA 3+10 | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101144184 |
| 240000067 | 240000067 | null | null | null | null | 2019-12-23 | DA 3 + 10 | null | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100888810 |
| 240000069 | 240000069 | null | null | null | null | 2017-09-11 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | null | null | AML18 TRIAL | 101343467 |
| 240000070 | 240000070 | 1.77 | null | Curative (C) | null | 2019-06-30 | Cisplatin 7 day | 02 | N | BENDAMUSTINE + RITUXIMAB | 100887969 |
| 240000078 | 240000078 | 1.82 | 113 | Curative (C) | 2019-07-22 | 2019-07-26 | Azacitidine | 02 | null | ALL UKALL2011 IND B | 100129625 |